Align Technology is using a Swiss oral health study to cement its dominance in digital dentistry. But who is truly owning the data?
Forget the hype. Moltbook, the supposed 'social media network for AI,' is less about collaboration and more about centralized data harvesting. We analyze the hidden risks.
The demise of Amazon Go stores isn't about tech failure. It's about consumer fatigue and the hidden cost of convenience in retail technology.
HCLTech and Guardian's new AI partnership isn't just about efficiency. It’s a seismic shift in insurance tech, but who is footing the bill for this 'transformation journey'?
Forget the 'set you up for life' hype. We dissect the hidden risks in popular tech stocks and reveal the true long-term winners.
Are wellness patches the future of health or a dangerous placebo? We expose the real winners profiting from your stress and libido woes.
The push for global health taxes on sugar and alcohol isn't just about wellness; it's a stealth move in fiscal policy. Unpacking the true winners.
Figure Technology Solutions valuation surge hides the real play: dominating the entire financial infrastructure, not just Q4 loan volumes.
The Ardent Health securities fraud lawsuit isn't just about investor losses; it signals a brutal consolidation phase in US healthcare.
Google's sudden halt on AI health summaries isn't about minor safety bugs; it's a calculated retreat from catastrophic legal exposure in the high-stakes world of digital health.
Aurobindo's CuraTeQ just snagged Health Canada approval for Dyrupeg, but this isn't just a regulatory win; it's a calculated strike in the escalating global **biosimilar market** battle.
Forget the hype around Marvell Technology's new buy rating. The real story is the deepening chasm in the semiconductor landscape and who pays the hidden tax.